
This case highlights the risk of corporate influence infiltrating medical training, potentially shaping future physicians’ priorities toward financial incentives over patient care. It underscores the importance of transparency and vigilance in academic‑industry collaborations, a timely concern as value‑based care models expand nationwide.
Comments
Want to join the conversation?
Loading comments...